ITEM 7.01REGULATION FD DISCLOSURE

On June 25, 2020, Vitro Diagnostics, Inc., a Nevada corporation (the "Company") issued a press release announcing results of operations and financial condition for its fiscal 2nd quarter year ended April 30, 2020. A copy of the Press Release is filed herewith as Exhibit 99.1.

The information in this Current Report on Form 8-K furnished pursuant to Item 7.01, including Exhibit 99.1, shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to liability under that section, and they shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. By filing this Current Report on Form 8-K and furnishing this information pursuant to Item 7.01, The Company makes no admission as to the materiality of any information in this Current Report on Form 8-K, including Exhibit 99.1, that is required to be disclosed solely by Regulation FD.







ITEM 9.01:EXHIBITS



  Item Title

  99.1   Press Release

© Edgar Online, source Glimpses